<DOC>
	<DOCNO>NCT00871767</DOCNO>
	<brief_summary>The aim study compare blood level achieve new formulation AZD5672 exist formulation AZD5672 use previous study</brief_summary>
	<brief_title>AZD5672 Bioavailability Study Healthy Male Female Subjects</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>N- ( 1- ( 3- ( 3,5-difluorophenyl ) -3- ( 4-methanesulfonylphenyl ) propyl ) piperidin-4-yl ) -N-ethyl-2- ( 4-methanesulfonylphenyl ) acetamide</mesh_term>
	<criteria>Provision inform consent prior studyspecific procedure BMI 18 30 kg/m2 Medical surgical history physical examination without clinically significant finding Non smoker past smoker stop smoke within last 6 month . History clinically significant cardio cerebrovascular , pulmonary , renal , hepatic , neurological , mental gastrointestinal disorder major disorder may interfere objective study , judge Investigator Clinically significant illness judge Investigator , within two week first administration investigational product . Female subject positive pregnancy test pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>AZD5672</keyword>
	<keyword>relative bioavailability</keyword>
	<keyword>rheumatoid arthritis ( RA )</keyword>
</DOC>